Alzheimer Disease Clinical Trial
Official title:
Studies of Brain and Body Interaction at Rutgers University
The goal of this study is to characterize biophysiolgoical signals as a comprehensive profile of the nervous systems in order to understand interactions between the brain and body, while an individual performs naturalistic behaviors (ex. walking, pointing) and while breathing at a slow controlled pace. The investigators aim to study these interactions among a variety of populations, from healthy individuals to those with disorders such as Autism Spectrum Disorder(s), including those who may also have an ADHD (Attention-deficit/hyperactivity disorder) diagnosis, Asperger's Syndrome, Alzheimer's Disease, and/or Fragile X syndrome
What is the study for? The goal of this study is to characterize biophysical signals
simultaneously co-registered from the person's nervous systems. To that end the investigators
use multiple wearable biosensors (electroencephalogram, electrocardiogram, kinematics,etc.)
and have the person move naturally during activities that are similar to what the person
would do in activities of daily living. These include walking, walking with a metronome in
the background and walking while breathing at the metronome's pace. The purpose of the study
is to learn about the inherent properties of the biorhythms of each person in order to build
a proper neurotypical scale and measure the departure of several groups of subjects from this
typical ranges. These include Autism Spectrum Disorder(s), ADHD
(Attention-deficit/hyperactivity disorder) , Asperger's Syndrome, Alzheimer's Disease, and/or
Fragile X syndrome. This study does not provide any recommendations of diagnosis or
treatment. It is merely a characterization of the person's biorhythms across these
conditions.
What will the participant do? The participant will perform naturalistic behaviors (ex. walk
naturally around the room, point at an object) while hearing a metronome beating in the
background. At certain points, the participant will be instructed to breathe along with the
beat of the metronome. During this experiment, the participant will be wearing a wireless
Electroencephalographic (EEG) cap to record brain activity, wireless motion sensors around
the body to record movement, and wireless electrocardiogram (ECG) on the chest to record
heart activity.The participant will also be wearing Zeblok insoles placed inside their shoes,
to monitor their gait. The recorded biophysical signals are to be used to assess biorhythms
of the nervous system from an already diagnosed participants and neurotypical participants,
as this experiment is designed to study and characterize the biophysical signals of various
populations. The study does not provide criteria for diagnosis, nor does it provide
recommendations for treatments. The study is merely characterizing the ranges of biophysical
data and their variability across different populations to measure departure from
neurotypical features. Please note, wearing a wireless EEG cap will involve applying
electrode gel (similar to hair gel) on the participant's hair.
How long is the experiment? The experiment itself will take 45 minutes - comprising 3 walking
trials lasting 15 minutes each - but this can be reduced depending on the participant's
disposition. Breaks for light refreshments and sensory toys will be provided as needed. The
setup will take an additional 15-30 minutes.
Where/when does the experiment take place? The experiment will be conducted at the
Sensory-motor Integration Lab, Psychology Building on Busch campus, at Rutgers University
(152 Frelinghuysen Road, Piscataway, NJ 08854). If necessary the experiment may also be
conducted at the participant's home. Based on the availability of the participant and the
experimenter, the date and place can be coordinated any day and time of the week - including
weekends. Additional members of staff can provide on-site childcare for siblings upon
request.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04079803 -
PTI-125 for Mild-to-moderate Alzheimer's Disease Patients
|
Phase 2 | |
Completed |
NCT04044495 -
Sleep, Rhythms and Risk of Alzheimer's Disease
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Recruiting |
NCT04520698 -
Utilizing Palliative Leaders In Facilities to Transform Care for Alzheimer's Disease
|
N/A | |
Active, not recruiting |
NCT04606420 -
Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05820919 -
Enhancing Sleep Quality for Nursing Home Residents With Dementia - R33 Phase
|
N/A | |
Terminated |
NCT03672474 -
REGEnLIFE RGn530 - Feasibility Pilot
|
N/A | |
Completed |
NCT03430648 -
Is Tau Protein Linked to Mobility Function?
|
||
Recruiting |
NCT04522739 -
Spironolactone Safety in African Americans With Mild Cognitive Impairment and Early Alzheimer's Disease
|
Phase 4 | |
Recruiting |
NCT04949750 -
Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease
|
N/A | |
Recruiting |
NCT05557409 -
A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation
|
Phase 3 | |
Recruiting |
NCT05288842 -
Tanycytes in Alzheimer's Disease and Frontotemporal Dementia
|
||
Completed |
NCT06194552 -
A Multiple Dose Study of the Safety and Pharmacokinetics of NTRX-07
|
Phase 1 | |
Completed |
NCT03239561 -
Evaluation of Tau Protein in the Brain of Participants With Alzheimer's Disease Compared to Healthy Participants
|
Early Phase 1 | |
Completed |
NCT03184467 -
Clinical Trial to Evaluate the Efficacy and Safety of GV1001 in Alzheimer Patients
|
Phase 2 | |
Active, not recruiting |
NCT03676881 -
Longitudinal Validation of a Computerized Cognitive Battery (Cognigram) in the Diagnosis of Mild Cognitive Impairment and Alzheimer's Disease
|
||
Terminated |
NCT03487380 -
Taxonomic and Functional Composition of the Intestinal Microbiome: a Predictor of Rapid Cognitive Decline in Patients With Alzheimer's Disease
|
N/A | |
Completed |
NCT05538455 -
Investigating ProCare4Life Impact on Quality of Life of Elderly Subjects With Neurodegenerative Diseases
|
N/A | |
Recruiting |
NCT05328115 -
A Study on the Safety, Tolerability and Immunogenicity of ALZ-101 in Participants With Early Alzheimer's Disease
|
Phase 1 | |
Completed |
NCT05562583 -
SAGE-LEAF: Reducing Burden in Alzheimer's Disease Caregivers Through Positive Emotion Regulation and Virtual Support
|
N/A |